References
- ACOG Practice Bulletin No. 89 (2008). Elective and riskreducing salpingo-oophorectomy. Obstet Gynecol, 111, 231-41. https://doi.org/10.1097/00006250-200801000-00039
- Asante A, Whiteman MK, Kulkarni A, et al (2010). Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006. Obstet Gynecol, 116, 1088-95. https://doi.org/10.1097/AOG.0b013e3181f5ec9d
- Casiano ER, Trabuco EC, Bharucha AE, et al (2013). Risk of oophorectomy after hysterectomy. Obstet Gynecol, 121, 1069-74. https://doi.org/10.1097/AOG.0b013e31828e89df
- Chan JK, Urban R, Capra AM, et al (2014). Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy. Obstet Gynecol, 123, 65-72. https://doi.org/10.1097/AOG.0000000000000061
- Cibula D, Widschwendter M, Majek O (2011). Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Hum Reprod Update, 17, 55-67. https://doi.org/10.1093/humupd/dmq030
- Dekel A, Efrat Z, Orvieto R, et al (1996). The residual ovary syndrome: a 20-year experience. Eur J Obstet Gynecol Reprod Biol, 68, 159-64. https://doi.org/10.1016/0301-2115(96)00250-3
- Ferlay J, Soerjomataram I, Dikshit R, et al (2012). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86.
- Greene MH, Mai PL, Schwartz PE (2013). Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol, 204, 1-6.
- Jacoby VL, Grady D, Wactawski-Wende J, et al (2011). Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med, 171, 760-8.
- Jansaka N, Suprasert P (2014). Survival outcomes of recurrent epithelial ovarian cancer: experience from a Thailand northern tertiary care center. Asian Pac J Cancer Prev, 15, 10837-40.
- Kontoravdis A, Kalogirou D, Antoniou G, et al (1996). Prophylactic oophorectomy in ovarian cancer prevention. Int J Gynaecol Obstet, 54, 257-62. https://doi.org/10.1016/0020-7292(96)02724-5
- Loft A, Lidegaard O, Tabor A (1997). Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up. Br J Obstet Gynaecol, 104, 1296-301. https://doi.org/10.1111/j.1471-0528.1997.tb10978.x
- Moore MA, Attasara P, Khuhaprema T, et al (2008). Cancer epidemiology in mainland South-East Asia - past, present and future. Asian Pac J Cancer Prev, 11, 67-80.
- Morelli M, Venturella R, Mocciaro R, et al (2013). Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol, 129, 448-51. https://doi.org/10.1016/j.ygyno.2013.03.023
- Muto MG, Cramer DW, Brown DL, et al (1993). Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center. Gynecol Oncol, 51, 12-20. https://doi.org/10.1006/gyno.1993.1239
- Naylor AC (1984). Hysterectomy--analysis of 2901 personally performed procedures. S Afr Med J, 65, 242-5.
- Parker WH, Broder MS, Liu Z, et al (2007). Ovarian conservation at the time of hysterectomy for benign disease. Clin Obstet Gynecol, 50, 354-61. https://doi.org/10.1097/GRF.0b013e31804a838d
- Parker WH, Feskanich D, Broder MS, et al (2009). Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstet Gynecol, 121, 709-16.
- Piver MS (1996). Prophylactic oophorectomy: reducing the U.S. death rate from epithelial ovarian cancer. A Continuing Debate. Oncologist, 1, 326-30.
- Plockinger B, Kolbl H (1994). Development of ovarian pathology after hysterectomy without oophorectomy. J Am Coll Surg, 178, 581-5.
- Rocca WA, Grossardt BR, de Andrade M, et al (2006). Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol, 7, 821-8. https://doi.org/10.1016/S1470-2045(06)70869-5
- Rozario D, Brown I, Fung MF, et al (1997). Is incidental prophylactic oophorectomy an acceptable means to reduce the incidence of ovarian cancer? Am J Surg, 173, 495-8. https://doi.org/10.1016/S0002-9610(97)00012-3
- Shuster LT, Gostout BS, Grossardt BR, et al (2008). Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int, 14, 111-6. https://doi.org/10.1258/mi.2008.008016
- Tantipalakorn C, Wanapirak C, Khunamornpong S, et al (2014). IOTA simple rules in differentiating between benign and malignant ovarian tumors. Asian Pac J Cancer Prev, 15, 5123-6. https://doi.org/10.7314/APJCP.2014.15.13.5123
- Whittemore AS, Harris R, Itnyre J (1992). Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. collaborative ovarian cancer group. Am J Epidemiol, 136, 1212-20. https://doi.org/10.1093/oxfordjournals.aje.a116429
- Woodward ER, Sleightholme HV, Considine AM, et al (2007). Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective. BJOG, 114, 1500-9. https://doi.org/10.1111/j.1471-0528.2007.01499.x
- Zalel Y, Lurie S, Beyth Y, et al (1997). Is it necessary to perform a prophylactic oophorectomy during hysterectomy? Eur J Obstet Gynecol Reprod Biol, 73, 67-70. https://doi.org/10.1016/S0301-2115(97)02702-4